News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19314)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3995)
November (3760)
December (3171)
Day
2 (247)
3 (169)
4 (135)
5 (129)
6 (103)
9 (104)
10 (152)
11 (155)
12 (168)
13 (118)
15 (3)
16 (213)
17 (193)
18 (180)
19 (178)
20 (108)
23 (180)
24 (160)
25 (150)
26 (140)
27 (98)
30 (173)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
15
16
17
18
19
20
23
24
25
26
27
30
Drug Development
Bristol-Myers Squibb Company Release: Phase 3 Study Evaluating Yervoy® (Ipilimumab) For Melanoma In An Adjuvant Setting Meets Primary Endpoint Of Recurrence-Free Survival
June 2, 2014
·
1 min read
Biotech Bay
Heron Therapeutics, Inc. Provides Update On SUSTOL Program
June 2, 2014
·
1 min read
Job Trends
Arrow International, Inc. To Significantly Downsize, Will Cost 600 North Carolina Jobs
June 2, 2014
·
1 min read
Policy
Organogenesis Inc. Sales Rep Charged With Stealing $350K Worth Of Skin Grafts
June 2, 2014
·
1 min read
FDA
OsteoSymbionics Announces FDA 510(K) Clearance For Using Novel Sterile Processing Process For Clearshield Implants
June 2, 2014
·
2 min read
Drug Development
Bristol-Myers Squibb Company Release: One- & Two-Year Survival Rates of 94% And 88% Announced From Phase 1b Trial Of Investigational PD-1 Checkpoint Inhibitor Nivolumab And Yervoy® (ipilimumab) In Advanced Melanoma; Ongoing Phase 2/3 Trials To Confirm Res
June 2, 2014
·
1 min read
Drug Development
Data on Merck & Co., Inc.’s Pembrolizumab From Largest Study To Date Of Investigational Anti-PD-1 Antibody In Advanced Melanoma Highlighted At American Society of Clinical Oncology 2014
June 2, 2014
·
1 min read
Biotech Beach
CareFusion Corporation To Launch Three New Infection Prevention Products At APIC 2014
June 2, 2014
·
5 min read
Drug Development
First Presentation Of Data For Pembrolizumab, Merck & Co., Inc.’s Investigational Anti-PD-1 Antibody, In Patients With Previously-Untreated, Advanced Non-Small Cell Lung Cancer (NSCLC) At American Society of Clinical Oncology 2014
June 2, 2014
·
1 min read
Policy
Medtronic, Inc. Won’t Face “Death Penalty” Sanctions Imposed By Texas State Court
June 2, 2014
·
1 min read
Previous
5 of 25
Next
